Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep 17;56(3):2001400.
doi: 10.1183/13993003.01400-2020. Print 2020 Sep.

Socioeconomic correlates of SARS-CoV-2 and influenza H1N1 outbreaks

Affiliations

Socioeconomic correlates of SARS-CoV-2 and influenza H1N1 outbreaks

Jan Christian Kaiser et al. Eur Respir J. .

Abstract

Geographic disease patterns of the SARS-CoV-2 and the H1N1 influenza pandemics are cross-examined with socioeconomic indices, revealing that the two outbreaks are fundamentally different and that SARS-CoV-2 spread is linked with economic output https://bit.ly/3fqkiyp

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: J.C. Kaiser has nothing to disclose. Conflict of interest: G.T. Stathopoulos has nothing to disclose.

Figures

FIGURE 1
FIGURE 1
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and H1N1 influenza pandemics in 27 countries. a) Colour-coded map and legend of the 27 countries analysed on 12 May 2020. b) Heatmap of the correlations observed on 12 May 2020. c–e) Significant bivariate correlations of the SARS-CoV 2 and H1N1 outbreaks with socioeconomic indices. Shown are color-coded raw data points, Pearson's correlation coefficients (R2) and probability values (p), and linear regression lines with 95% confidence intervals (grey zones). GDP: annual gross domestic product. f–h) Crude rates for population-adjusted SARS-CoV-2 deaths and cases and H1N1 deaths in comparison with country-specific rates expected by the preferred general linear model.

References

    1. Munster VJ, Koopmans M, van Doremalen N, et al. A novel coronavirus emerging in China – key questions for impact assessment. N Engl J Med 2020; 382: 692–694. doi: 10.1056/NEJMp2000929 - DOI - PubMed
    1. Parmet WE, Sinha MS. Covid-19 – the law and limits of quarantine. N Engl J Med 2020; 382: e28. doi: 10.1056/NEJMp2004211 - DOI - PubMed
    1. Studdert DM, Hall MA. Disease control, civil liberties, and mass testing - calibrating restrictions during the Covid-19 pandemic. N Engl J Med 2020; 383: 102–104. doi: 10.1056/NEJMp2007637 - DOI - PubMed
    1. Kraemer MUG, Yang CH, Gutierrez B, et al. The effect of human mobility and control measures on the COVID-19 epidemic in China. Science 2020; 368: 493–497. doi: 10.1126/science.abb4218 - DOI - PMC - PubMed
    1. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators . Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390: 1211–1259. doi: 10.1016/S0140-6736(17)32154-2 - DOI - PMC - PubMed

MeSH terms